BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

CGI Pharmaceuticals Inc.

CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule kinase inhibitors for a broad range of oncology/angiogenesis and autoimmune/allergic/inflammatory disease indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary discovery biology and chemistry, extensive lead generation capabilities, as well as preclinical and growing clinical development expertise.


Contact Details:
36 East Industrial Road
Branford
Connecticut
06405
United States of America
Tel:(203) 315-1222
Fax:(203) 488-7838
Email:jobs@cgipharma.com
WWW:

www.cgipharma.com/




Loading...

Recent Publications by CGI Pharmaceuticals Inc.:

Chemical genetic approaches to kinase drug discovery.
Chemical genetics is an important approach in biological research that...
18th October, 2005
CGI Pharmaceuticals Inc, 36 East Industrial Road, Branford, CT 06405, USA. Curr Opin Drug Discov Devel. 2005 Sep;8(5):638-45.

BioNews Results for CGI Pharmaceuticals Inc.:

Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Tr
KRON4:  Sep 26 2008 5:51AM Matching: cgi pharmaceuticals inc
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Tr
SmartBrief:  Sep 26 2008 3:25AM Matching: cgi pharmaceuticals inc
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Tr
KSLA:  Sep 26 2008 7:48AM Matching: cgi pharmaceuticals inc
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Tr
KOTA Territory News:  Sep 26 2008 1:32AM Matching: cgi pharmaceuticals inc
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Tr
Atlanta Business Chronicle:  Sep 25 2008 6:23PM Matching: cgi pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution

View more CGI Pharmaceuticals Inc. news.

CGI Pharmaceuticals Inc. Patents:

US Patent No.Title
7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
7393848 Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
7312341 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
7259164 Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
7189723 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity

View more CGI Pharmaceuticals Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 153 times since April 2007, the link to the organisation's website has been followed 27 times

Recent Search Terms used to find this page: t | @cgipharma.com and director and bio | .

Search for more companies in Branford

Search for more companies in Connecticut



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CGI Pharmaceuticals Inc.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.